First Time Loading...

BioNTech SE
NASDAQ:BNTX

Watchlist Manager
BioNTech SE Logo
BioNTech SE
NASDAQ:BNTX
Watchlist
Price: 92.13 USD -0.16% Market Closed
Updated: May 15, 2024
Section:
 

Relative Value

The Relative Value of one BNTX stock under the Base Case scenario is 45.15 USD. Compared to the current market price of 92.13 USD, BioNTech SE is Overvalued by 51%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BNTX Relative Value
Base Case
45.15 USD
Overvaluation 51%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

5.3
P/S
P/S
Price to Sales
5.3
vs History
21
vs Industry
65
Median 3Y
2.9
Median 5Y
2
Industry
8.2
Forward
7.1
More Details
21.8
P/E
P/E
Price to Earnings
21.8
vs History
14
vs Industry
8
Median 3Y
5.4
Median 5Y
3.7
Industry
27.4
Forward
-48.6
More Details
3.8
P/OCF
P/OCF
Price to OCF
3.8
vs History
31
vs Industry
14
Median 3Y
3.7
Median 5Y
2.6
Industry
24.3
More Details
4.4
P/FCFE
P/FCFE
Price to FCFE
4.4
vs History
31
vs Industry
11
Median 3Y
4.1
Median 5Y
2.9
Industry
23
More Details
1
P/B
P/B
Price to Book Value
1
vs History
92
vs Industry
62
Median 3Y
1.9
Median 5Y
2.7
Industry
2.6
More Details
1
EV/S
EV/S
Enterprise Value to Sales
1
vs History
54
vs Industry
77
Median 3Y
1.3
Median 5Y
1.1
Industry
7.5
Forward
1.4
More Details
1.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.2
vs History
56
vs Industry
75
Median 3Y
1.5
Median 5Y
1.3
Industry
9.3
More Details
3.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
3.7
vs History
42
vs Industry
12
Median 3Y
1.9
Median 5Y
2.4
Industry
4.3
Forward
-10.2
More Details
4.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
4.4
vs History
21
vs Industry
11
Median 3Y
2
Median 5Y
1.7
Industry
4.2
Forward
-5.4
More Details
0.7
EV/OCF
EV/OCF
Enterprise Value to OCF
0.7
vs History
52
vs Industry
19
Median 3Y
1.3
Median 5Y
0.8
Industry
5.9
More Details
0.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
0.9
vs History
52
vs Industry
14
Median 3Y
1.4
Median 5Y
0.9
Industry
3.3
More Details
0.7
EV/IC
EV/IC
Enterprise Value to IC
0.7
vs History
92
vs Industry
65
Median 3Y
2.2
Median 5Y
2.7
Industry
4.9
More Details

Multiples Across Competitors

BNTX Competitors Multiples
BioNTech SE Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
BioNTech SE
NASDAQ:BNTX
22B USD 5.3 21.8 3.7 4.4
US
Abbvie Inc
NYSE:ABBV
288.5B USD 5.3 59.9 13 19.8
US
Amgen Inc
NASDAQ:AMGN
171.3B USD 5.8 45.6 19.1 31.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.8B USD 11.4 31.2 25.2 26.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
107.5B USD 8.2 27.9 22.5 25
AU
CSL Ltd
ASX:CSL
136.7B AUD 6.4 36.6 22.1 27.4
US
Gilead Sciences Inc
NASDAQ:GILD
84.4B USD 3.1 174.2 7 9.2
US
Moderna Inc
NASDAQ:MRNA
49B USD 9.5 -8.2 -9 -8
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
34.3B USD 3.6 29.5 14.9 18.6
KR
Celltrion Inc
KRX:068270
39.6T KRW 18.2 73.8 45.2 62.2

See Also

Summary
BNTX intrinsic value, competitors valuation, and company profile.
DCF Valuation
BNTX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BNTX stock valuation using valuation multiples.
Wall Street Estimates
BNTX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BNTX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.